Literature DB >> 21631422

Mechanisms and inhibitors of apoptosis in cardiovascular diseases.

Sylvia S Singh1, Peter M Kang.   

Abstract

Apoptosis or progress of programmed cell death is a tightly regulated process which plays an important role in various cardiovascular diseases particularly in myocardial infarction, reperfusion injury, and heart failure. Over the past two decades, investigations of several pathways have broadened our understanding of programmed cell death. Many anti-apoptotic interventions have targeted ischemia-reperfusion, however only a limited number have been considered at the chronic stage of heart failure. Endogenous inhibitors, caspase inhibitors, PARP-1 inhibitors, as well as various other agents have been implicated as anti-apoptotic interventions. This review summarizes the apoptotic pathways associated with heart failure, discusses the current anti-apoptotic interventions available and reviews the clinical implications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21631422     DOI: 10.2174/138161211796390994

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  15 in total

1.  Reversion of left ventricle remodeling in spontaneously hypertensive rats by valsartan is associated with the inhibition of caspase-3, -8 and -9 activities.

Authors:  X U Deng; K E Xia; P O Chen; Md Sayed Ali Sheikh; DA-Feng Yang; Si-Min Li; Tian-Lun Yang
Journal:  Biomed Rep       Date:  2015-04-29

Review 2.  Striking a balance: autophagy, apoptosis, and necrosis in a normal and failing heart.

Authors:  Wajihah Mughal; Rimpy Dhingra; Lorrie A Kirshenbaum
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

Review 3.  Mitochondria play a central role in nonischemic cardiomyocyte necrosis: common to acute and chronic stressor states.

Authors:  M Usman Khan; Yaser Cheema; Atta U Shahbaz; Robert A Ahokas; Yao Sun; Ivan C Gerling; Syamal K Bhattacharya; Karl T Weber
Journal:  Pflugers Arch       Date:  2012-02-11       Impact factor: 3.657

4.  Hesperetin protects against cardiac remodelling induced by pressure overload in mice.

Authors:  Wei Deng; Duan Jiang; Yi Fang; Heng Zhou; Zhihong Cheng; Yafen Lin; Rui Zhang; Jieyu Zhang; Peng Pu; Yuan Liu; Zhouyan Bian; Qizhu Tang
Journal:  J Mol Histol       Date:  2013-05-30       Impact factor: 2.611

5.  Inhibition of ubiquitin-activating enzyme protects against organ injury after intestinal ischemia-reperfusion.

Authors:  Shingo Matsuo; Andrew Chaung; Deanna Liou; Ping Wang; Weng-Lang Yang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-05-17       Impact factor: 4.052

6.  Nuclear factor-κB activation inhibitor attenuates ischemia reperfusion injury and inhibits Hmgb1 expression.

Authors:  Zhiyong Shi; Aimin Lian; Fuquan Zhang
Journal:  Inflamm Res       Date:  2014-09-11       Impact factor: 4.575

7.  Effects of metabolic acidosis on intracellular pH responses in multiple cell types.

Authors:  Ahlam Ibrahim Salameh; Vernon A Ruffin; Walter F Boron
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-09-10       Impact factor: 3.619

8.  Labdane diterpenes protect against anoxia/reperfusion injury in cardiomyocytes: involvement of AKT activation.

Authors:  I Cuadrado; M Fernández-Velasco; L Boscá; B de Las Heras
Journal:  Cell Death Dis       Date:  2011-11-10       Impact factor: 8.469

9.  Target network differences between western drugs and Chinese herbal ingredients in treating cardiovascular disease.

Authors:  Peng Fu; Linlin Yang; Yi Sun; Li Ye; Zhiwei Cao; Kailin Tang
Journal:  BMC Bioinformatics       Date:  2014-03-19       Impact factor: 3.169

10.  The antioxidant compound tert-butylhydroquinone activates Akt in myocardium, suppresses apoptosis and ameliorates pressure overload-induced cardiac dysfunction.

Authors:  Yongtao Zhang; Fang Fang Liu; Xiaolei Bi; Shuangxi Wang; Xiao Wu; Fan Jiang
Journal:  Sci Rep       Date:  2015-08-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.